Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Lymphoma · Multiple Myeloma · Non-Hodgkin Lymphoma · Relapsed Hodgkin's Disease, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Study coordinator (Karmanos Cancer Institute) · info@karmanos.org · 800-527-6266
Contact: Principal Investigator (Joseph P Uberti, MD)
Columbia University, New York, New York, United States
Contact: Study coordinator (Research Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
Contact: Principal Investigator (Divaya Bhutani, MD)

Study leads

Divaya Bhutani
Principal Investigator
Columbia University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Recurrent B-Cell Non-Hodgkin Lymphoma · Recurrent Multiple Myeloma · Refractory B-Cell Non-Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Columbus, United States

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Brain Cancer · Breast Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Duarte, United States · Miami, United States

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States